Neuralstem (CUR) News Today

Notice: This company has been marked as potentially delisted and may not be actively trading.
SourceHeadline
lse.co.uk logoAguas Da Curia Share Price (CUR.LS)
lse.co.uk - November 25 at 8:24 PM
seekingalpha.com logoXAUUSD:CUR Gold Spot Price
seekingalpha.com - August 22 at 3:27 PM
thestreet.com logo4 Biotech Stocks Under $10 Moving Higher
thestreet.com - July 20 at 3:23 PM
seekingalpha.com logoXPTUSD:CUR Platinum Spot Price
seekingalpha.com - June 28 at 1:20 PM
seekingalpha.com logoXAUUSD:CUR
seekingalpha.com - May 16 at 11:17 AM
marketscreener.com logoNovAccess Global : Announces Fireside Chat with Board Member Perspectives - Marketscreener.com
marketscreener.com - October 20 at 9:12 AM
news.yahoo.com logoAnti-inflammatory compound supercharges stem cell stroke treatment - Yahoo News
news.yahoo.com - October 12 at 3:55 PM
businessinsider.com logoBest microscope photos of 2022 reveal stunning hidden world around us - Business Insider
businessinsider.com - October 11 at 2:30 PM
benzinga.com logoStem Cell Manufacturing Global Market Report 2022: Widespread Product Utilization in Effective Disease Ma - Benzinga
benzinga.com - October 11 at 9:29 AM
globenewswire.com logoAruna Bio Announces Presentation on Neural Exosome Treatment Opportunities and Lead Program, AB126 at Exosome Based Therapeutic Development Summit - GlobeNewswire
globenewswire.com - October 6 at 8:32 AM
streetinsider.com logoBOLDEN THERAPEUTICS RECEIVES $406,466 SBIR GRANT FROM THE NATIONAL INSTITUTE ON AGING TO SUPPORT DEVELOPMENT OF ANTISENSE OLIGONUCLEOTIDES TO PROMOTE NEUROGENESIS - StreetInsider.com
streetinsider.com - September 16 at 1:40 PM
prnewswire.com logoBGI-led Research Builds the World's First Spatiotemporal Map of Brain Regeneration - PR Newswire
prnewswire.com - September 2 at 5:00 AM
globenewswire.com logoGlobal Recurrent Glioblastoma Pipeline Insight | Clinical Trials Research Report 2022 by DelveInsight - GlobeNewswire
globenewswire.com - August 23 at 6:14 PM
newsweek.com logoHow Scientists Successfully Reversed Alzheimer's in Mice - Newsweek
newsweek.com - August 23 at 4:44 AM
techcrunch.com logoDioseve wants to help infertile people with tech that grows egg cells - TechCrunch
techcrunch.com - August 22 at 11:44 PM
finance.yahoo.com logoThe Global Stem Cell Manufacturing Market grew USD 4,378.00 million by 2027, at a CAGR of 12.23%. - Yahoo Finance
finance.yahoo.com - August 12 at 7:25 PM
globenewswire.com logoThe Global Stem Cell Manufacturing Market grew USD 4,378.00 - GlobeNewswire
globenewswire.com - August 12 at 9:59 AM
finance.yahoo.com logoCalidi Biotherapeutics Announces FDA Authorization of IND for a Phase 1 Clinical Trial of NeuroNova in Patients with Recurrent High-Grade Glioma - Yahoo Finance
finance.yahoo.com - August 4 at 2:53 AM
businesswire.com logoCalidi Biotherapeutics Announces FDA Authorization of IND for a Phase 1 Clinical Trial of NeuroNova in Patients with Recurrent High-Grade Glioma - Business Wire
businesswire.com - August 2 at 8:45 AM
in.investing.com logoHow chickenpox virus is linked to onset of Alzheimer's disease - Investing.com India
in.investing.com - August 1 at 2:13 AM
forbes.com logoCan Inflammation Lead To Cognitive Issues? Past Research Says 'Yes', With Implications For Covid-19 - Forbes
forbes.com - July 21 at 5:41 PM
abcnews.go.com logoHigh-flying experiment: Do stem cells grow better in space? - ABC News
abcnews.go.com - July 17 at 12:54 PM
streetinsider.com logojCyte Announces Appointment of Dr. Stewart Craig as Chief Technology Officer - StreetInsider.com
streetinsider.com - July 12 at 10:49 PM
forbes.com logoResearch On Flies Provides Hope For Brain Repair - Forbes
forbes.com - July 11 at 6:30 PM
finance.yahoo.com logoStem Cell Assays Market Report 2022-2027: Government Initiatives to Boost Stem Cell Research Present Opportunities - Yahoo Finance
finance.yahoo.com - July 7 at 9:20 PM
bizjournals.com logoThe Albany College of Pharmacy's plans at the Center for Medical Science building - Albany Business Review - The Business Journals
bizjournals.com - July 7 at 9:20 PM
uk.finance.yahoo.com logoGlobal Stem Cell Assays Market Projected to Reach $4.5 Billion by 2027 - Yahoo Finance UK
uk.finance.yahoo.com - July 6 at 6:42 PM
globenewswire.com logoGlobal Stem Cell Assays Market Projected to Reach $4.5 Billion by 2027 - GlobeNewswire
globenewswire.com - July 6 at 7:31 AM
businesswire.com logoStem Cell Assays Market Report 2022-2027: Increasing Awareness About Therapeutic Potency of Stem Cells Driving Growth - ResearchAndMarkets.com - Business Wire
businesswire.com - July 5 at 9:23 AM
finance.yahoo.com logoStem Cell Assays Market worth $4.5 billion by 2027 – Exclusive Report by MarketsandMarkets™ - Yahoo Finance
finance.yahoo.com - July 5 at 4:22 AM
bizjournals.com logoAlbany College of Pharmacy and Health Sciences buys Center For Medical Science building - Albany Business Review - The Business Journals
bizjournals.com - June 30 at 9:26 PM
prnewswire.com logoBOLDEN THERAPEUTICS RECEIVES $497,500 SBIR GRANT FROM THE NATIONAL INSTITUTE ON AGING TO SUPPORT DEVELOPMENT OF ANTISENSE OLIGONUCLEOTIDES TO PROMOTE NEUROGENESIS - PR Newswire
prnewswire.com - June 29 at 3:21 PM
finance.yahoo.com logoStem Cell Assays Market worth $4.5 billion by 2027 - Exclusive Report by MarketsandMarkets™ - Yahoo Finance
finance.yahoo.com - June 21 at 1:20 PM
prnewswire.com logoARUNA BIO ANNOUNCES ISSUANCE OF A NEW COMPOSITION OF MATTER PATENT COVERING NEURAL EXOSOMES IN JAPAN - PR Newswire
prnewswire.com - June 13 at 9:56 AM
prnewswire.com logoChung-Ang University Researchers Use Biomolecule-Loaded Metal-Organic Frameworks Nanopatterns to Aid Artificial Stem Cell Differentiation - PR Newswire
prnewswire.com - June 10 at 3:59 PM
finance.yahoo.com logoUTSA awards $4 million to Oskar Fischer Prize recipients for innovative explanations of Alzheimer's disease - Yahoo Finance
finance.yahoo.com - June 8 at 10:19 AM
prnewswire.com logoAruna Bio Advances Therapeutic Development for Traumatic Brain Injury - PR Newswire
prnewswire.com - May 31 at 9:30 PM
businesswire.com logoLUXA BIO Announces First Participant Dosed in Phase 1/2a Clinical Trial of Adult RPESC-RPE-4W for Dry Age-related Macular Degeneration - Business Wire
businesswire.com - May 24 at 11:43 AM
marketscreener.com logoINTERNATIONAL STEM CELL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - Marketscreener.com
marketscreener.com - May 13 at 6:48 PM
globenewswire.com logoUnited States to Lead Global Induced Pluripotent Stem Cell (iPSC) Market Growth: Fact.MR Analysis - GlobeNewswire
globenewswire.com - May 5 at 3:45 PM
streetinsider.com logoGenenta Science (GNTA) Announces Nomination of Mark A. Sirgo as Chair - StreetInsider.com
streetinsider.com - April 28 at 8:32 PM
prnewswire.com logoARUNA BIO APPOINTS STEPHEN FROM AS CHIEF EXECUTIVE OFFICER - PR Newswire
prnewswire.com - April 27 at 6:48 PM
uk.finance.yahoo.com logoGenenta Announces Nomination of Mark A. Sirgo as Chair - Yahoo Finance UK
uk.finance.yahoo.com - April 27 at 1:48 PM
prnewswire.com logo2022 Lurie Prize in Biomedical Sciences Winners Provide Powerful Contributions to Our Understanding of the Aging Process - PR Newswire
prnewswire.com - April 14 at 10:11 AM
marketscreener.com logoINTERNATIONAL STEM CELL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) - Marketscreener.com
marketscreener.com - March 29 at 5:37 PM
finance.yahoo.com logoAgeX Therapeutics Reports Fourth Quarter and Annual 2021 Financial Results - Yahoo Finance
finance.yahoo.com - March 29 at 5:37 PM
marketscreener.com logoNOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Changes in Control or Registra - Marketscreener.com
marketscreener.com - March 14 at 4:53 PM
marketscreener.com logoKringle Pharma : Files Patent Application for Treatment of Chronic Spinal Cord Injury - Marketscreener.com
marketscreener.com - March 11 at 4:56 AM
finance.yahoo.com logoCalidi Biotherapeutics and Edoc Acquisition Corp. Agree to Merge and Create a Publicly Listed, Clinical-Stage Biotechnology Company Utilizing Stem Cell-Based Platforms to Revolutionize Oncolytic Virotherapies - Yahoo Finance
finance.yahoo.com - February 3 at 2:23 AM
forbes.com logoHow ‘Dormant’ Cells In The Aging Brain Contribute To Cognitive Decline - Forbes
forbes.com - February 1 at 2:51 AM
Get Neuralstem News Delivered to You Automatically

Sign up to receive the latest news and ratings for CUR and its competitors with MarketBeat's FREE daily newsletter.

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

CUR Media Mentions By Week

CUR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CUR
News Sentiment

0.00

0.32

Average
Medical
News Sentiment

CUR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CUR Articles
This Week

0

0

CUR Articles
Average Week

Get Neuralstem News Delivered to You Automatically

Sign up to receive the latest news and ratings for CUR and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:CUR) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners